Sign In
Buy ATNM
$1.11
-0.0500 (-4.31%)
At Close: Jun 04, 2026
Is Apria (APR) Stock Outpacing Its Medical Peers This Year?
03:00pm, Tuesday, 11'th Jan 2022 Zacks Investment Research
Here is how Apria (APR) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.
Actinium: SIERRA Is Progressing Well Towards Final Data Readout
09:05am, Thursday, 16'th Dec 2021
Actinium: SIERRA Is Progressing Well Towards Final Data Readout
Actinium Reports Positive Findings From Phase 1 Study Of Actimab-A
01:57pm, Tuesday, 14'th Dec 2021 FinanzNachrichten
WASHINGTON (dpa-AFX) - Actinium Pharmaceuticals, Inc. (ATNM) reported updated data from the recently complete Actimab-A and CLAG-M phase 1 combination trial for patients with relapsed or refractor
Actinium Reports Positive Findings From Phase 1 Study Of Actimab-A - Quick Facts
01:37pm, Tuesday, 14'th Dec 2021 Business Insider Markets
(RTTNews) - Actinium Pharmaceuticals, Inc. (ATNM) reported updated data from the recently complete Actimab-A and CLAG-M phase 1 combination trial for patients with relapsed or refractory AML. Key findings from the study include: complete remissions in all dose cohorts; 72% MRD negativity rate; and 80% overall response rate in patients receiving…
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
11:07am, Monday, 06'th Dec 2021 Benzinga
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative development. The sector r
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Shares Acquired by Vanguard Group Inc.
09:12am, Saturday, 20'th Nov 2021 Dakota Financial News
Vanguard Group Inc. lifted its stake in shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) by 43.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 819,642 shares of the biotechnology companys stock after buying an additional 247,122 shares during the period. Vanguard Group Inc. owned approximately []
NEW YORK, Oct. 1, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with
Actinium to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 29th
08:00am, Tuesday, 28'th Sep 2021
NEW YORK, Sept. 28, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with
Actinium to Present at Four Upcoming Investor Conferences
08:36am, Monday, 20'th Sep 2021
NEW YORK, Sept. 20, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with
BWXT Medical, Bayer AG Ink Agreement On Actinium-225
10:24am, Thursday, 16'th Sep 2021
Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at [email protected] Trending
Actinium Completes Enrollment in the Pivotal Phase 3 SIERRA Trial of Iomab-B
07:00am, Wednesday, 15'th Sep 2021
NEW YORK, Sept. 15, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that it has completed enrollment of the pivotal Phase 3 S
Actinium: A Story Of Delays And Promises, About To Come To Fruition
09:21am, Thursday, 15'th Jul 2021
Actinium: A Story Of Delays And Promises, About To Come To Fruition
Actinium Pharmaceuticals Announces Inclusion in Russell Microcap® Index
08:30am, Monday, 28'th Jun 2021
NEW YORK, June 28, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced today that it will be added to the Russell Microcap® Inde
NEW YORK, June 17, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that its intellectual property portfolio around its lead P
Actinium's Targeted Radiotherapy Achieves 100% Bone Marrow Transplant Engraftment
02:27pm, Tuesday, 15'th Jun 2021
Actinium Pharmaceuticals Inc (NYSE: ATNM) highlighted data from its pivotal Phase 3 SIERRA trial evaluating Iomab-B in patients with relapsed or refractory Acute Myeloid Leukemia (AML) aged 55 year
